Casaevades

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Por um escritor misterioso
Last updated 06 abril 2025
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection - ScienceDirect
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Frontiers The Phage Nucleus and PhuZ Spindle: Defining Features of the Subcellular Organization and Speciation of Nucleus-Forming Jumbo Phages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Conquering CRISPR: how phages overcome bacterial adaptive immunity - ScienceDirect
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Frontiers Biological and Molecular Characterization of a Jumbo Bacteriophage Infecting Plant Pathogenic Ralstonia solanacearum Species Complex Strains
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Intracellular Organization by Jumbo Bacteriophages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III RNA targeting provides protection against jumbo phage
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A Jumbo Formation in the Viral Game Plan
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
PDF) A nucleus-forming jumbophage evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Genomic characterization of four novel bacteriophages infecting the clinical pathogen Klebsiella pneumoniae
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Bacteriophage cooperation suppresses CRISPR-Cas3 and Cas9 immunity; Anti- CRISPR phages cooperate to overcome CRISPR-Cas immunity - preLights
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Frontiers Biological and Molecular Characterization of a Jumbo Bacteriophage Infecting Plant Pathogenic Ralstonia solanacearum Species Complex Strains
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection
Recomendado para você
você pode gostar

© 2014-2025 likytut.eu. All rights reserved.